Teva Pharmaceutical Industries Limited in Court Over AstraZeneca PLC’s Seroquel Patent

January 24, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters -- Israel's Teva Pharmaceutical Industries (TEVA.O) has launched a High Court action in London to revoke the European patent for Seroquel, an anti-depressant developed by AstraZeneca (AZN.L), the Sunday Times reported.

Twitter
LinkedIn
Facebook
Email
Print

Legal

AstraZeneca Pharmaceuticals LP